Prometheus Biosciences Inc. logo

Prometheus Biosciences Inc.

RXDX | NASDAQ
Chart Builder DCF Calculator
$199.92
+$0.18 (+0.09%)
At close: Jun 15, 2023, 04:00 PM ET

Market Data

Market Cap
$9.56B
Enterprise Value
$8.87B
Beta
-0.49
Average Volume
N/A
Shares Outstanding (Diluted)
47.46M
Shares Change YoY
21.67%
Institutional Ownership
N/A
Exchange
N/A
ISIN
N/A

Price Performance

Price Change 1M
N/A
Price Change 3M
N/A
Price Change 6M
N/A
Price Change YTD
N/A
Price Change 1Y
N/A
Price Change 3Y
N/A
Price Change 5Y
N/A
1M CAGR (ann.)
2.9%
1Y CAGR (ann.)
700.3%
5Y CAGR (ann.)
N/A
All-Time CAGR
149.6%

Valuation

PE Ratio
-57.28
Forward PE
N/A
PEG Ratio
2.75
Forward PEG
2.75
PS Ratio
2,392.62
Forward PS
N/A
PB Ratio
13.70
P/FCF Ratio
-70.44
P/Adj. FCF Ratio
-58.77
P/OCF Ratio
-65.98
EV/Sales
2,221.35
EV/EBIT
-55.63
EV/EBITDA
-55.25
EV/FCF
-65.40
Earnings Yield
-1.8%
FCF Yield
-1.4%
Adj. FCF Yield
-1.7%

Financial Health

Net Cash
$684.21M
Total Debt
$29.46M
Cash & Short-Term Investments
$713.67M
Total Assets
$758.41M
Current Ratio
31.04
Quick Ratio
31.08
Debt / Equity Ratio
0.04
Debt / EBITDA
-0.18
Debt / FCF
-0.22
OCF / Debt
-4.53
Interest Coverage
0.00
Altman Z-Score
94.04
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-4064.7%
EBITDA Margin
-2131.7%
Net Profit Margin
-2081.8%
FCF Margin
-3396.4%
Adj. FCF Margin
-4071.4%
SBC / Revenue
306.4%
SBC Impact (per share)
-19.9%

Returns

Return on Assets
-19.1%
Return on Equity
-31.1%
Return on Invested Capital
-20.2%
Return on Capital Employed
-20.3%
Return on Tangible Assets
-19.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
159.7%
Revenue CAGR 5Y
57.2%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-43.9%
EPS CAGR 5Y
-17.8%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-55.4%
FCF CAGR 5Y
-22.3%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
11
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Aug 9, 2023
EPS Estimate (next Q)
-$0.91
EPS Growth Est (next Q)
1.1%
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$138.57
Price Target Upside
-30.7%

Cash Flow

Operating Cash Flow
$-133.41M
Free Cash Flow
$-135.69M
Adj. Free Cash Flow
$-162.65M
FCF Per Share
-$3.10
OCF Per Share
-$3.03
OCF/S Ratio
-1810.2%

Income Statement

Revenue
$4M
Gross Profit
$4M
Operating Income
$-162.39M
EBITDA
$-160.63M
Net Income
$-149.13M
EPS (Diluted)
-$3.49
Revenue / Employee
N/A
Profit / Employee
N/A
Employees
N/A

© 2026 bestshares.com. All rights reserved.